QIAGEN Genomics Enters Into Tuberculosis SNP Genotyping Research And License Agreement with TIGR and MMC
Groups Collaborate to Analyze Genetic Variation in Different Strains of M. Tuberculosis
16-Mar-2001 -
QIAGEN
Genomics, Inc., a wholly-owned subsidiary of QIAGEN N.V.
(Nasdaq: QGENF; Frankfurt/Neuer Market: QIA: Easdaq:
QGEN) today announced that it has entered into a
research and license agreement with The Institute for
Genomic Research (TIGR) and the Montefiore Medical
Center (MMC) ...
chemistry
evolution
Fraser
+11